• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

西方饮食诱导的非酒精性脂肪性肝病小鼠模型与代谢结局相关:肠道微生物群-肝脏-脂肪组织轴的特征。

Western diet-induced mouse model of non-alcoholic fatty liver disease associated with metabolic outcomes: Features of gut microbiome-liver-adipose tissue axis.

机构信息

São Paulo State University (UNESP), Botucatu Medical School, Department of Pathology, Botucatu, Brazil; São Paulo State University (UNESP), Biosciences Institute, Department of Structural and Functional Biology, Botucatu, Brazil.

São Paulo State University (UNESP), Biosciences Institute, Department of Structural and Functional Biology, Botucatu, Brazil; Federal University of Grande Dourados (UFGD), Dourados, MS, Brazil.

出版信息

Nutrition. 2022 Nov-Dec;103-104:111836. doi: 10.1016/j.nut.2022.111836. Epub 2022 Aug 29.

DOI:10.1016/j.nut.2022.111836
PMID:36202025
Abstract

OBJECTIVES

Non-alcoholic fatty liver disease (NAFLD) has a growing epidemiologic and economic burden. It is associated with Western diet (WD) patterns, and its pathogenesis involves metabolic disorders (obesity, dyslipidemia, hyperglycemia, and diabetes) and gut dysbiosis, features that are usually neglected or not reproduced by most animal models. Thus, we established a 6-mo WD-induced NAFLD mouse model associated with metabolic disorder, investigating its main features at the gut microbiome-liver-adipose tissue axis, also evaluating the correlations of gut dysbiosis to the other disease outcomes.

METHODS

Male C57 BL6 mice received a high-fat (30% lard and 0.2% cholesterol, ∼57% calories) and sucrose-rich (20%) chow, and a high-sugar solution (23.1 and 18.9 g/L of D-fructose and D-glucose) for 6 mo.

RESULTS

The model featured high serum cholesterol levels, glucose intolerance, and hyperinsulinemia. WD intervention resulted in extensive macro/microvesicular liver steatosis and pericellular fibrosis-resembling human disease-accompanied by hepatic stellate cell activation and CD68+ macrophage infiltration, increased protein levels of proinflammatory p65-nuclear factor-κB, interleukin-6 and tumor necrosis factor-α, with decreased antioxidant regulator Nrf2. Mice showed clear obesity with adipocyte hypertrophy, and CD68+macrophage/mast cell infiltration in adipose tissue while a reduction in number of goblet cells was also observed in the small intestine. Moreover, the pyrosequencing of the 16 S ribosomal RNA of gut cecal content showed decreased bacterial diversity, enriched Firmicutes and Proteobacteria, decreased Bacteroidetes and Fusobacteria, and increased ratio of Firmicutes to Bacteroidetes. Bacteroidetes and Bacteroides had the highest number of significant correlations with liver-adipose tissue axis outcomes. In silico analysis of gut microbiome in NAFLD obese patients revealed a depletion in Bacteroides, which also correlated to disease outcomes.

CONCLUSION

This mice model gathered suitable phenotypical alterations in gut-liver-adipose tissue axis that resembled NAFLD associated with metabolic disorders in humans and may be considered for preclinical investigation.

摘要

目的

非酒精性脂肪性肝病(NAFLD)的流行病学和经济负担日益加重。它与西方饮食(WD)模式有关,其发病机制涉及代谢紊乱(肥胖、血脂异常、高血糖和糖尿病)和肠道菌群失调,这些特征通常被大多数动物模型所忽视或无法重现。因此,我们建立了一个 6 个月的 WD 诱导的 NAFLD 小鼠模型,该模型与代谢紊乱有关,研究了其在肠道微生物组-肝脏-脂肪组织轴上的主要特征,同时还评估了肠道菌群失调与其他疾病结果的相关性。

方法

雄性 C57BL6 小鼠接受高脂肪(30%猪油和 0.2%胆固醇,约 57%热量)和富含蔗糖(20%)的饲料,以及高糖溶液(23.1 和 18.9 g/L 的 D-果糖和 D-葡萄糖),持续 6 个月。

结果

该模型表现出高血清胆固醇水平、葡萄糖不耐受和高胰岛素血症。WD 干预导致广泛的大/微泡性肝脂肪变性和细胞周纤维化,类似于人类疾病,伴有肝星状细胞激活和 CD68+巨噬细胞浸润,促炎 p65-核因子-κB、白细胞介素-6 和肿瘤坏死因子-α的蛋白水平升高,抗氧化调节剂 Nrf2 减少。小鼠表现出明显的肥胖,脂肪细胞肥大,脂肪组织中 CD68+巨噬细胞/肥大细胞浸润,同时小肠中杯状细胞数量减少。此外,肠道盲肠内容物 16S 核糖体 RNA 的焦磷酸测序显示细菌多样性减少,厚壁菌门和变形菌门富集,拟杆菌门和梭杆菌门减少,厚壁菌门与拟杆菌门的比例增加。拟杆菌门和拟杆菌属与肝-脂肪组织轴结果的相关性最高。对 NAFLD 肥胖患者肠道微生物组的计算分析显示,拟杆菌属减少,这也与疾病结果相关。

结论

该小鼠模型聚集了在肠道-肝脏-脂肪组织轴上适合表型改变的 NAFLD,与人类代谢紊乱相关的 NAFLD 相似,可用于临床前研究。

相似文献

1
Western diet-induced mouse model of non-alcoholic fatty liver disease associated with metabolic outcomes: Features of gut microbiome-liver-adipose tissue axis.西方饮食诱导的非酒精性脂肪性肝病小鼠模型与代谢结局相关:肠道微生物群-肝脏-脂肪组织轴的特征。
Nutrition. 2022 Nov-Dec;103-104:111836. doi: 10.1016/j.nut.2022.111836. Epub 2022 Aug 29.
2
Modifying effects of 2,4-D and Glyphosate exposures on gut-liver-adipose tissue axis of diet-induced non-alcoholic fatty liver disease in mice.2,4-D 和草甘膦暴露对饮食诱导的非酒精性脂肪肝病小鼠肠道-肝脏-脂肪组织轴的修饰作用。
Ecotoxicol Environ Saf. 2023 Dec;268:115688. doi: 10.1016/j.ecoenv.2023.115688. Epub 2023 Nov 22.
3
Metabolic phenotype and adipose and liver features in a high-fat Western diet-induced mouse model of obesity-linked NAFLD.在高脂西方饮食诱导的肥胖相关非酒精性脂肪性肝病小鼠模型中的代谢表型以及脂肪和肝脏特征
Am J Physiol Endocrinol Metab. 2016 Mar 15;310(6):E418-39. doi: 10.1152/ajpendo.00319.2015. Epub 2015 Dec 15.
4
Integrated omics analysis unraveled the microbiome-mediated effects of Yijin-Tang on hepatosteatosis and insulin resistance in obese mouse.整合组学分析揭示了益津糖通过调节肠道微生物群对肥胖小鼠肝脂肪变性和胰岛素抵抗的影响。
Phytomedicine. 2020 Dec;79:153354. doi: 10.1016/j.phymed.2020.153354. Epub 2020 Sep 21.
5
Gut Dysbiosis Shaped by Cocoa Butter-Based Sucrose-Free HFD Leads to Steatohepatitis, and Insulin Resistance in Mice.可可脂基无蔗糖高脂肪饮食导致的肠道菌群失调会引发小鼠脂肪性肝炎和胰岛素抵抗。
Nutrients. 2024 Jun 18;16(12):1929. doi: 10.3390/nu16121929.
6
Protective effect of quercetin on high-fat diet-induced non-alcoholic fatty liver disease in mice is mediated by modulating intestinal microbiota imbalance and related gut-liver axis activation.槲皮素对高脂饮食诱导的小鼠非酒精性脂肪性肝病的保护作用是通过调节肠道微生物群失衡和相关肠-肝轴激活来介导的。
Free Radic Biol Med. 2017 Jan;102:188-202. doi: 10.1016/j.freeradbiomed.2016.11.037. Epub 2016 Nov 25.
7
Perilipin-2 promotes obesity and progressive fatty liver disease in mice through mechanistically distinct hepatocyte and extra-hepatocyte actions. perilipin-2 通过不同的肝细胞和肝外细胞作用机制促进肥胖和进行性脂肪性肝病的发生。
J Physiol. 2019 Mar;597(6):1565-1584. doi: 10.1113/JP277140. Epub 2019 Jan 2.
8
aggravates high-fat diet-induced non-alcoholic fatty liver disease by regulating lipid metabolism and remodeling gut microbiota.通过调节脂质代谢和重塑肠道微生物群加重高脂肪饮食诱导的非酒精性脂肪肝疾病。
Microbiol Spectr. 2024 Apr 2;12(4):e0339323. doi: 10.1128/spectrum.03393-23. Epub 2024 Feb 27.
9
Bacteroides ovatus alleviates high-fat and high-cholesterol -induced nonalcoholic fatty liver disease via gut-liver axis.卵形拟杆菌通过肠-肝轴缓解高脂肪和高胆固醇诱导的非酒精性脂肪肝疾病。
Biomed Pharmacother. 2024 Sep;178:117156. doi: 10.1016/j.biopha.2024.117156. Epub 2024 Jul 19.
10
Bilberry Anthocyanins Ameliorate NAFLD by Improving Dyslipidemia and Gut Microbiome Dysbiosis.越橘花色苷通过改善血脂异常和肠道微生物群落失调改善非酒精性脂肪性肝病。
Nutrients. 2020 Oct 23;12(11):3252. doi: 10.3390/nu12113252.

引用本文的文献

1
New Insights into the Interplay Between Simple Sugars and Liver Diseases.单糖与肝脏疾病相互作用的新见解
Curr Issues Mol Biol. 2025 May 23;47(6):390. doi: 10.3390/cimb47060390.
2
Advancing hepatotoxicity assessment: current advances and future directions.推进肝毒性评估:当前进展与未来方向
Toxicol Res. 2025 Apr 24;41(4):303-323. doi: 10.1007/s43188-025-00289-w. eCollection 2025 Jul.
3
A diet-driven metabolic dysfunction-associated steatohepatitis (MASH) mouse model resembles the corresponding human disease.饮食驱动的代谢功能障碍相关脂肪性肝炎(MASH)小鼠模型类似于相应的人类疾病。
J Mol Histol. 2025 May 20;56(3):162. doi: 10.1007/s10735-025-10449-9.
4
Unraveling MASLD: The Role of Gut Microbiota, Dietary Modulation, and AI-Driven Lifestyle Interventions.解析代谢相关脂肪性肝病:肠道微生物群、饮食调节及人工智能驱动的生活方式干预的作用
Nutrients. 2025 May 4;17(9):1580. doi: 10.3390/nu17091580.
5
Dietary Influences on Gut Microbiota and Their Role in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD).饮食对肠道微生物群的影响及其在代谢功能障碍相关脂肪性肝病(MASLD)中的作用
Nutrients. 2024 Dec 31;17(1):143. doi: 10.3390/nu17010143.
6
Curcumin Mitigates Gut Dysbiosis and Enhances Gut Barrier Function to Alleviate Metabolic Dysfunction in Obese, Aged Mice.姜黄素减轻肥胖老年小鼠的肠道菌群失调并增强肠道屏障功能,以缓解代谢功能障碍。
Biology (Basel). 2024 Nov 21;13(12):955. doi: 10.3390/biology13120955.
7
Gut microbiota and mycobiota change with feeding duration in mice on a high-fat and high-fructose diet.高脂肪高果糖饮食喂养的小鼠,其肠道菌群和真菌群落随喂养时间而变化。
BMC Microbiol. 2024 Nov 29;24(1):504. doi: 10.1186/s12866-024-03663-0.
8
Gut microbiota, serum metabolites, and lipids related to blood glucose control and type 1 diabetes.肠道微生物群、血清代谢物与血糖控制和 1 型糖尿病相关的脂质。
J Diabetes. 2024 Oct;16(10):e70021. doi: 10.1111/1753-0407.70021.
9
Ovariectomy and High Fat-Sugar-Salt Diet Induced Alzheimer's Disease/Vascular Dementia Features in Mice.卵巢切除术和高脂肪高糖高盐饮食诱导的小鼠阿尔茨海默病/血管性痴呆特征。
Aging Dis. 2024 Oct 1;15(5):2284-2300. doi: 10.14336/AD.2024.03110.
10
Understanding the role of ursodeoxycholic acid and gut microbiome in non-alcoholic fatty liver disease: current evidence and perspectives.了解熊去氧胆酸和肠道微生物群在非酒精性脂肪性肝病中的作用:当前证据与展望。
Front Pharmacol. 2024 Mar 21;15:1371574. doi: 10.3389/fphar.2024.1371574. eCollection 2024.